These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2769482)

  • 1. Null cell adenomas of the pituitary gland. An immunohistochemical study.
    Holm R; Nesland JM; Attramadal A; Halse J; Johannessen JV
    J Pathol; 1989 Jul; 158(3):213-7. PubMed ID: 2769482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analyses of oncocytic and chromophobe pituitary adenomas.
    Günzl HJ; Saeger W; Diehl S; Lüdecke DK
    Exp Clin Endocrinol; 1988 Sep; 92(1):51-8. PubMed ID: 2465910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subclinical adenomas of the human pituitary. New light on old problems.
    McComb DJ; Ryan N; Horvath E; Kovacs K
    Arch Pathol Lab Med; 1983 Sep; 107(9):488-91. PubMed ID: 6309114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathology of nonfunctional pituitary adenomas.
    Martinez AJ
    Semin Diagn Pathol; 1986 Feb; 3(1):83-94. PubMed ID: 3303231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis of RCAS1 in human pituitary adenomas.
    Umeoka K; Sanno N; Oyama K; Tahara S; Kurotani R; Ikuyama S; Nakashima M; Watanabe T; Osamura RY; Teramoto A
    Mod Pathol; 2001 Dec; 14(12):1232-6. PubMed ID: 11743045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative immunohistochemical analysis of estrogen receptor and chromogranin-A reactivity in plurihormonal human prolactinomas.
    Talan-Hranilović J; Gnjidić Z; Sajko T; Vizner B; Vrkljan M
    Acta Med Croatica; 2000; 54(2):59-63. PubMed ID: 11028110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical localization of chromogranin in human hypophyses and pituitary adenomas.
    Lloyd RV; Wilson BS; Kovacs K; Ryan N
    Arch Pathol Lab Med; 1985 Jun; 109(6):515-7. PubMed ID: 2986572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of pituitary homeo box 1 (Ptx1) in human non-neoplastic pituitaries and pituitary adenomas.
    Tahara S; Kurotani R; Sanno N; Takumi I; Yoshimura S; Osamura RY; Teramoto A
    Mod Pathol; 2000 Oct; 13(10):1097-108. PubMed ID: 11048804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p75 and TrkC neurotrophin receptors demonstrate a different immunoreactivity profile in comparison to TrkA and TrkB receptors in human normal pituitary gland and adenomas.
    Assimakopoulou M; Zolota V; Chondrogianni C; Gatzounis G; Varakis J
    Neuroendocrinology; 2008; 88(2):127-34. PubMed ID: 18319596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of somatostatin-14 and the receptor-specific somatostatin analogs on chromogranin A and alpha-subunit (alpha-SU) release from "clinically nonfunctioning" pituitary adenoma cells incubated in vitro.
    Pawlikowski M; Lawnicka H; Pisarek H; Kunert-Radek J; Radek M; Culler MD
    J Physiol Pharmacol; 2007 Mar; 58(1):179-88. PubMed ID: 17440235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Rab3, a Ras-related GTP-binding protein, in human nontumorous pituitaries and pituitary adenomas.
    Tahara S; Sanno N; Teramoto A; Osamura RY
    Mod Pathol; 1999 Jun; 12(6):627-34. PubMed ID: 10392640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical demonstration of tenascin in human pituitary glands and adenomas.
    Ikeda H; Yoshimoto T; Fujiwara K; Ogawa Y
    Acta Histochem; 1995 Jul; 97(3):273-80. PubMed ID: 8525784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plurihormonal pituitary adenomas.
    Scheithauer BW; Horvath E; Kovacs K; Laws ER; Randall RV; Ryan N
    Semin Diagn Pathol; 1986 Feb; 3(1):69-82. PubMed ID: 3039632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunohistochemistry for pituitary hormones and Ki-67 in growth hormone producing pituitary adenomas].
    Brito J; Sáez L; Lemp M; Liberman C; Michelsen H; Araya AV
    Rev Med Chil; 2008 Jul; 136(7):831-6. PubMed ID: 18949157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
    Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
    Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic relevance of intracytoplasmic cytokeratin pattern, hormone expression profile, and cell proliferation in pituitary adenomas of akromegalic patients.
    Mazal PR; Czech T; Sedivy R; Aichholzer M; Wanschitz J; Klupp N; Budka H
    Clin Neuropathol; 2001; 20(4):163-71. PubMed ID: 11495005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human gonadotropic adenoma: pathologic diagnosis and hormonal correlations in 26 tumors.
    Trouillas J; Girod C; Sassolas G; Claustrat B
    Semin Diagn Pathol; 1986 Feb; 3(1):42-57. PubMed ID: 3112888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical localization of synaptophysin in human hypophyses and pituitary adenomas.
    Stefaneanu L; Ryan N; Kovacs K
    Arch Pathol Lab Med; 1988 Aug; 112(8):801-4. PubMed ID: 3134875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and immunohistochemical studies on TSH-secreting pituitary adenoma: its multihormonality and expression of Pit-1.
    Sanno N; Teramoto A; Matsuno A; Inada K; Itoh J; Osamura RY
    Mod Pathol; 1994 Dec; 7(9):893-9. PubMed ID: 7892156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different expression of chromogranin A and chromogranin B in various types of pituitary adenomas.
    Riva C; Leutner M; Capella C; Usellini L; la Rosa S; Brianza MR; Buffa R
    Zentralbl Pathol; 1993 Jun; 139(2):165-70. PubMed ID: 8396420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.